Cherwell Laboratories, the established cleanroom microbiology specialist will transition to AnalytiChem UK from September 2025, marking the completion of its integration with the global AnalytiChem Group whilst maintaining its 54-year heritage in pharmaceutical manufacturing support and quality control solutions.
Clinical-stage radiopharmaceutical company ARTBIO has completed a substantial $132 million Series B financing round to advance its pipeline of alpha radioligand therapies, expand manufacturing capabilities, and support Phase II development of lead candidate AB001 for metastatic castration-resistant prostate cancer.
GEA’s new 40,000-square-metre facility in Elsdorf, Germany represents a strategic expansion into pharmaceutical freeze-drying systems, addressing surging global demand for vaccine and injectable drug manufacturing technologies. The investment demonstrates significant industry confidence in lyophilisation technology advancement.
Advancing clinical diagnostics through analytical excellence
Automated chemiluminescence immunoassay (ChLIA) systems are nowadays a mainstay for many diagnostic laboratories. Euroimmun has joined forces with Immunodiagnostic Systems (IDS) to offer an extensive portfolio of diagnostic solutions based on ChLIA technology. Clinical Laboratory International talked to Dr. Anna Stanisak, Global Product Manager for Automation at Euroimmun to find out more.
Congratulations to Finlay MacKenzie and Dr Rachel Marrington of Birmingham Quality [one of the main providers of clinical biochemistry external quality assessment (EQA) schemes in the UK] on receipt of their Impact Award presented at this year’s LabMedUK meeting in Manchester. This prestigious award recognizes their outstanding work on patient-centric EQA for acute kidney injury […]
A global leader in liquid-stable reagents
Pioneering next-generation clinical diagnostics through innovation and sustainability
Although great developments have been made in treating lung cancer, it remains the most common cause of cancer deaths, largely because patients present late with advanced disease. Timely and accurate reporting of biomarker analysis is crucial for directing physicians to the most appropriate therapy for the patient. CLI chatted to Dr Brandon Sheffield (molecular pathologist […]
Bio-Rad Laboratories has significantly expanded its droplet digital PCR (ddPCR) capabilities with the launch of four new platforms, combining internal development with strategic acquisition expertise. The company’s enhanced portfolio now delivers the most comprehensive digital PCR solutions available for life science research and diagnostic applications.
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.